Literature DB >> 18469200

Coactivator function of RIP140 for NFkappaB/RelA-dependent cytokine gene expression.

Inka Zschiedrich1, Ulrike Hardeland, Anja Krones-Herzig, Mauricio Berriel Diaz, Alexandros Vegiopoulos, Johannes Müggenburg, Dirk Sombroek, Thomas G Hofmann, Rainer Zawatzky, Xiaolei Yu, Norbert Gretz, Mark Christian, Roger White, Malcolm G Parker, Stephan Herzig.   

Abstract

Inflammatory responses represent a hallmark of numerous pathologies including sepsis, bacterial infection, insulin resistance, and malign obesity. Here we describe an unexpected coactivator function for the nuclear receptor interacting protein 140 (RIP140) for nuclear factor kappaB (NFkappaB), a master transcriptional regulator of inflammation in multiple tissues. Previous work has shown that RIP140 suppresses the expression of metabolic gene networks, but we have found that genetic as well as acute deficiency of RIP140 leads to the inhibition of the proinflammatory program in macrophages. The ability of RIP140 to function as a coactivator for cytokine gene promoter activity relies on direct protein-protein interactions with the NFkappaB subunit RelA and histone acetylase cAMP-responsive element binding protein (CREB)-binding protein (CBP). RIP140-dependent control of proinflammatory gene expression via RelA/CBP may, therefore, represent a molecular rational for the cellular integration of metabolic and inflammatory pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18469200     DOI: 10.1182/blood-2007-11-121699

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  38 in total

1.  Downregulation of RIP140 in hepatocellular carcinoma promoted the growth and migration of the cancer cells.

Authors:  Dexiang Zhang; Yueqi Wang; Yuedi Dai; Jiwen Wang; Tao Suo; Hongtao Pan; Han Liu; Sheng Shen; Houbao Liu
Journal:  Tumour Biol       Date:  2014-11-13

2.  Meeting report: nuclear receptors: transcription factors and drug targets connecting basic research with translational medicine.

Authors:  Jan Tuckermann; William Bourguet; Susanne Mandrup
Journal:  Mol Endocrinol       Date:  2010-06-02

3.  Cholesterol regulation of receptor-interacting protein 140 via microRNA-33 in inflammatory cytokine production.

Authors:  Ping-Chih Ho; Kun-Che Chang; Ya-Shan Chuang; Li-Na Wei
Journal:  FASEB J       Date:  2011-02-01       Impact factor: 5.191

Review 4.  Biological activities of receptor-interacting protein 140 in adipocytes and metabolic diseases.

Authors:  Ping-Chih Ho; Li-Na Wei
Journal:  Curr Diabetes Rev       Date:  2012-11

Review 5.  RIP140, a Janus metabolic switch involved in defense functions.

Authors:  Hun Taeg Chung
Journal:  Cell Mol Immunol       Date:  2012-12-17       Impact factor: 11.530

Review 6.  Transcriptional control of mitochondrial biogenesis and its interface with inflammatory processes.

Authors:  Claude A Piantadosi; Hagir B Suliman
Journal:  Biochim Biophys Acta       Date:  2012-01-14

7.  Involvement of receptor-interacting protein 140 in estrogen-mediated osteoclasts differentiation, apoptosis, and bone resorption.

Authors:  Hongying Piao; Xiaojie Chu; Wentao Lv; Yan Zhao
Journal:  J Physiol Sci       Date:  2016-03-26       Impact factor: 2.781

8.  Elevated expression of the metabolic regulator receptor-interacting protein 140 results in cardiac hypertrophy and impaired cardiac function.

Authors:  Asmaà Fritah; Jennifer H Steel; Donna Nichol; Nadeene Parker; Sharron Williams; Anthony Price; Leena Strauss; Timothy A Ryder; Margaret A Mobberley; Matti Poutanen; Malcolm Parker; Roger White
Journal:  Cardiovasc Res       Date:  2010-01-18       Impact factor: 10.787

9.  Control of adipose tissue inflammation through TRB1.

Authors:  Anke Ostertag; Allan Jones; Adam J Rose; Maria Liebert; Stefan Kleinsorg; Anja Reimann; Alexandros Vegiopoulos; Mauricio Berriel Diaz; Daniela Strzoda; Masahiro Yamamoto; Takashi Satoh; Shizuo Akira; Stephan Herzig
Journal:  Diabetes       Date:  2010-06-03       Impact factor: 9.461

Review 10.  Role of extracellular and intracellular microRNAs in sepsis.

Authors:  Kobina Essandoh; Guo-Chang Fan
Journal:  Biochim Biophys Acta       Date:  2014-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.